JAN HENDRICKSON: Open Payments
NPI 1811520802 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 19 payments from 8 companies in 2025. Trend: 2023 $83 · 2024 $316 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $144 |
| ViiV Healthcare Company | 4 | $118 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| Merck Sharp & Dohme LLC | 3 | $45 |
| PFIZER INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Astellas Pharma US Inc | 1 | $27 |
| Lilly USA, LLC | 1 | $14 |
Products named: DOVATO, APRETUDE, INSPIRE, PIFELTRO, Veozah, PREVNAR 20, AIRSUPRA, MOUNJARO.
Industry payments across NE — which companies pay providers there.
